Korean OB-GYN association adopts Univax's 'MDcount' drug inventory management system

The Korean Society of Obstetrics and Gynecology is set to adopt MDcount, a pharmaceutical inventory management system developed by IT company Univax.

The society announced Thursday that it had signed a partnership agreement with Univax to improve vaccine and pharmaceutical management at obstetrics and gynecology clinics, and that it would distribute MDcount to those facilities.

The partnership was established to systematically manage information covering the full lifecycle of vaccines and in-clinic pharmaceuticals — from receipt and use to returns and disposal. The initiative aims to reduce repetitive inventory checks and record-keeping tasks, raising the standard of vaccine safety management and in-clinic pharmaceutical operations.

MDcount is a web-based integrated management system that tracks the inflow and outflow of vaccines and in-clinic pharmaceuticals, current stock levels, lot numbers, expiration dates and items nearing expiry, and temperature logs. For vaccines, users can also retrieve required documentation such as supply-and-demand ledgers, inventory survey forms and temperature record sheets.

Through the rollout of MDcount, the society plans to create a safer vaccination environment and a more efficient pharmaceutical management framework at member clinics.

The partnership also incorporates Univax's patented automatic safety-stock ordering system for pharmaceuticals.

The system automatically triggers orders based on a clinic's current stock levels and item-specific reorder thresholds. It is expected to help obstetrics and gynecology clinics reduce the risk of sudden stockouts and missed orders, ensuring they can secure needed pharmaceuticals in a timely manner.

The society and Univax plan to expand the MDcount rollout to obstetrics and gynecology clinics free of charge, and will continue to improve features and services to better suit clinical environments.

Kim Jae-yeon, president of the Korean Society of Obstetrics and Gynecology, said the system is expected to "reduce the burden of manually checking stock levels or missing order windows, allowing medical staff to focus more on patients."

Kang Young-tae, chief executive of Univax, said the company would "use our patented automatic safety-stock ordering technology to maintain appropriate quantities for each item and ensure a smooth ordering process, substantially reducing the operational burden of pharmaceutical management at the point of care."

Meanwhile, Univax is a healthcare technology company that supports pharmaceutical inventory management at medical institutions, connecting safety-stock management, automatic ordering and supply through its patented technology.